12:00 AM
Dec 16, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

OTO-104: Phase IIb started

Otonomy began a double-blind, placebo-controlled, North American, pivotal Phase IIb trial to evaluate a single intratympanic injection of 12 mg OTO-104 in about 140 patients. Otonomy also...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >